Humira’s Approval Widened to Include Ulcerative Colitis

September 28, 2012

FRIDAY, Sept. 28 (HealthDay News) — Humira (adalimumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe ulcerative colitis in adults, the agency said Friday.
Humira — a type of drug called an anti-tumor necrosis factor that’s designed to suppress abnormal inflammatory and immune responses — has already been approved to treat […]

Worm Therapy Shows Promise for Ulcerative Colitis

December 1, 2010

By Julia VanTineHealthDay Reporter
WEDNESDAY, Dec. 1 (HealthDay News) — The case of a man who swallowed parasite eggs to treat his ulcerative colitis — and actually got better — sheds light on how “worm therapy” might help heal the gut, a new study suggests.
“Our findings in this case report suggest that infection with the eggs […]

Non-Invasive Diagnosis of Inflammatory Bowel Disease Shows Promise

July 16, 2010

FRIDAY, July 16 (HealthDay News) — Getting tested for inflammatory bowel disease through an endoscopy isn’t a pleasant experience, but a new review of existing research suggests that a simple stool test may help doctors figure out who needs the more extensive screening.
Inflammatory bowel disease refers to a number of conditions — including Crohn’s […]

Gene Sequencing Yields Picture of Human Gut

March 4, 2010

Researchers have succeeded in sequencing 3.3 million genes from organisms residing in the human gut.

Protein Appears Key to Intestinal Balance

February 19, 2010

A protein that plays a key role in protecting the intestinal tract from bacterial infection and inflammation has been identified by U.S. researchers.

Drugs for Inflammatory Bowel Might Increase Cancer Risk

October 19, 2009

The use of thiopurine drugs to treat inflammatory bowel disease (IBD) increases the risk of cancers related to viral infection, according to a new study.

One-Quarter of Biologic Drugs Have Had Safety Issues

October 22, 2008

New research shows that almost one-quarter of biologic therapies approved in the United States and Europe since 1995 have been the subject of at least one safety-related regulatory action in the decade since they were approved.

FDA to List Drugs Under Review for Safety Issues

September 7, 2008

The U.S. Food and Drug Administration has started listing on its website drugs being evaluated for potential safety issues, the agency said Friday.

FDA Starts Safety Review of Autoimmune Disorder Drugs

June 4, 2008

WEDNESDAY, June 4 (HealthDay News) — U.S. health officials have started a safety review of a class of drugs known as tumor necrosis factor (TNF) blockers, which are widely prescribed to treat autoimmune disorders such as rheumatoid arthritis, juvenile rheumatoid arthritis and Crohn’s disease.

Powered by VIP